Squarepoint’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-344,312
Closed -$23.9M 3061
2025
Q1
$23.9M Buy
344,312
+281,827
+451% +$19.6M 0.03% 317
2024
Q4
$5.37M Buy
62,485
+41,936
+204% +$3.61M 0.01% 738
2024
Q3
$2.45M Sell
20,549
-67,676
-77% -$8.06M ﹤0.01% 1046
2024
Q2
$12.6M Buy
88,225
+57,248
+185% +$8.17M 0.02% 406
2024
Q1
$3.98M Buy
+30,977
New +$3.98M 0.01% 781
2023
Q4
Sell
-3,908
Closed -$355K 2810
2023
Q3
$355K Sell
3,908
-112,282
-97% -$10.2M ﹤0.01% 1825
2023
Q2
$9.4M Buy
116,190
+95,542
+463% +$7.73M 0.03% 386
2023
Q1
$1.64M Sell
20,648
-7,856
-28% -$625K 0.01% 924
2022
Q4
$1.93M Buy
28,504
+11,268
+65% +$763K 0.01% 800
2022
Q3
$859K Sell
17,236
-28,926
-63% -$1.44M ﹤0.01% 1146
2022
Q2
$2.57M Sell
46,162
-39,380
-46% -$2.19M 0.01% 662
2022
Q1
$4.75M Buy
85,542
+46,698
+120% +$2.59M 0.02% 504
2021
Q4
$2.18M Buy
38,844
+29,414
+312% +$1.65M 0.01% 825
2021
Q3
$453K Sell
9,430
-3,338
-26% -$160K ﹤0.01% 1432
2021
Q2
$535K Sell
12,768
-114,388
-90% -$4.79M ﹤0.01% 1565
2021
Q1
$4.29M Buy
127,156
+64,594
+103% +$2.18M 0.03% 470
2020
Q4
$2.19M Buy
62,562
+28,068
+81% +$980K 0.02% 715
2020
Q3
$1.2M Sell
34,494
-74,338
-68% -$2.58M 0.02% 858
2020
Q2
$3.56M Sell
108,832
-48,956
-31% -$1.6M 0.06% 444
2020
Q1
$4.75M Sell
157,788
-152,266
-49% -$4.58M 0.12% 212
2019
Q4
$8.97M Buy
310,054
+62,200
+25% +$1.8M 0.05% 325
2019
Q3
$6.41M Buy
247,854
+42,654
+21% +$1.1M 0.06% 383
2019
Q2
$5.24M Buy
+205,200
New +$5.24M 0.05% 419